Lam King Hei Stanley, Wu Yung-Tsan, Reeves Kenneth Dean, Hadzic Admir, Perez Mario Fajardo, Fu Sau Nga
The Hong Kong Institute of Musculoskeletal Medicine, Unit 305 Telford House, 16 Wang Hoi Road, Kowloon Bay, Kowloon, Hong Kong.
Department of Family Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong.
Ther Adv Musculoskelet Dis. 2023 Jan 31;15:1759720X221149954. doi: 10.1177/1759720X221149954. eCollection 2023.
Knee osteoarthritis (OA) is common. Ultrasound-guided intra-articular injection (UGIAI) using the superolateral approach is currently the gold standard for treating knee OA, but it is not 100% accurate, especially in patients with no knee effusion. Herein, we present a case series of chronic knee OA treated with a novel infrapatellar approach to UGIAI. Five patients with chronic grade 2-3 knee OA, who had failed on conservative treatments and had no effusion but presented with osteochondral lesions over the femoral condyle, were treated with UGIAI with different injectates using the novel infrapatellar approach. The first patient was initially treated using the traditional superolateral approach, but the injectate was not delivered intra-articularly and became trapped in the pre-femoral fat pad. The trapped injectate was aspirated in the same session due to interference with knee extension, and the injection was repeated using the novel infrapatellar approach. All patients who received the UGIAI using the infrapatellar approach had the injectates successfully delivered intra-articularly, as confirmed with dynamic ultrasound scanning. Their Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain, stiffness, and function scores significantly improved 1 and 4 weeks post-injection. UGIAI of the knee using a novel infrapatellar approach is readily learned and may improve accuracy of UGIAI, even for patients with no effusion.
膝骨关节炎(OA)很常见。目前,采用上外侧入路的超声引导下关节内注射(UGIAI)是治疗膝骨关节炎的金标准,但它并非100%准确,尤其是在没有膝关节积液的患者中。在此,我们展示了一系列采用新型髌下入路进行UGIAI治疗的慢性膝骨关节炎病例。五例慢性2-3级膝骨关节炎患者,保守治疗失败,无积液,但股骨髁有骨软骨损伤,采用新型髌下入路用不同注射剂进行UGIAI治疗。首例患者最初采用传统上外侧入路治疗,但注射剂未注入关节内,而是滞留在股前脂肪垫中。由于影响膝关节伸展,在同一次治疗中抽出了滞留的注射剂,并采用新型髌下入路重复注射。所有采用髌下入路进行UGIAI治疗的患者,经动态超声扫描证实,注射剂均成功注入关节内。注射后1周和4周,他们的西安大略和麦克马斯特大学骨关节炎指数(WOMAC)疼痛、僵硬和功能评分显著改善。采用新型髌下入路进行膝关节UGIAI操作容易掌握,即使对于没有积液的患者,也可能提高UGIAI的准确性。